Filing Details
- Accession Number:
- 0001493152-22-033573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-23 16:29:52
- Reporting Period:
- 2022-11-21
- Accepted Time:
- 2022-11-23 16:29:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650389 | Eric Forman | 680 E. Colorado Blvd., Suite 180 Pasadena CA 91101 | Vice President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-21 | 1,457 | $0.56 | 99,599 | No | 4 | P | Indirect | Eric Forman Revocable Trust |
Common Stock | Acquisiton | 2022-11-22 | 2,484 | $0.56 | 102,083 | No | 4 | P | Indirect | Eric Forman Revocable Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Eric Forman Revocable Trust |
No | 4 | P | Indirect | Eric Forman Revocable Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 38,598 | Direct |